期刊文献+

托珠单抗治疗成人斯蒂尔病6例疗效观察 被引量:1

下载PDF
导出
摘要 目的:探讨托珠单抗治疗成人斯蒂尔病(AOSD)的临床疗效和不良反应。方法:选取本院确诊的6例AOSD患者,接受托珠单抗4~6mg/kg,1次/月,3个月及以上治疗,评价治疗效果。结果:应用托珠单抗治疗后肿胀关节数目、压痛关节数目、ESR、CRP、转氨酶、铁蛋白均较治疗前下降。治疗3个月后所有患者发热、皮疹缓解。随访中1例应用托珠单抗治疗后出现过敏性皮炎。未见严重不良反应。结论:托珠单抗能够有效缓解AOSD临床症状,可能是治疗AOSD的一个新选择。治疗过程中未见严重不良反应,安全性高。
出处 《北方药学》 2018年第3期43-43,共1页 Journal of North Pharmacy
  • 相关文献

参考文献1

二级参考文献16

  • 1Gaffe A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis. A m J Health Syst Pharm,2006,63 : 2451-2465.
  • 2Dayer JM, Choy E. Therapeutic targets in rheumatoid arthritis : the interleukin-6 receptor. Rheumatology (Oxford) ,2010,49 : 15-24.
  • 3Nishimoto N, Kishirnoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol,2006 ,2 :619-626.
  • 4Wolfe F, Michaud K. Anemia and renal function in patients with rheumatoid arthritis. J Rheumato1,2006,33 : 1516-1522.
  • 5Jongen-Lavrencic M, Peeters HR, Rozemuller H, et al. IL-6- induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations. Clin Exp Immunol, 1996,103:328-334.
  • 6I Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J,2003,374( Pt 1 ) :1-20.
  • 7Genovese MC, McKay JD, Nasonov EL, et al. lnterleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs : the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum,2008,58 : 2968 -2980.
  • 8Emery P, Keystone E, Tony HP, et al, IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis,2008,67 : 1516-1523.
  • 9Nishimoto N, Hashimoto J, Miyasaka N, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor ( SAMURAI ) : evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trim of tocilizumab. Ann Rheum Dis,2007,66 : 1162-1167.
  • 10Hashimoto J, Garnero P, Miyasaka N, et al. Early changes in biochemical markers of cartilage turnover and synovial inflammation predict the effects of tocilizumab monotherapy on one- year radiographic progression in patients with early rheumatoid arthritis [ abstract 1. Arthritis Rheum, 2006,54 Suppl : $410.

共引文献29

同被引文献14

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部